Rothschild & CO Asset Management Us Inc. Ptc Therapeutics, Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$46.8 - $68.92 $6.39 Million - $9.41 Million	-136,604 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$47.96 - $67.64 $103,833 - $146,440	2,165 Added 1.61%	136,604 $8.34 Million
Q3 2020 Nov 09, 2020	BUY	$45.41 - $57.07 $211,247 - $265,489	4,652 Added 3.58%	134,439 $6.29 Million
Q2 2020 Aug 10, 2020	BUY	$42.56 - $54.98 $76,310 - $98,579	1,793 Added 1.4%	129,787 $6.59 Million
Q1 2020 May 14, 2020	BUY	$32.37 - $59.36 $3.55 Million - $6.51 Million	109,701 Added 599.69%	127,994 $5.71 Million
Q4 2019 Feb 12, 2020	SELL	$32.22 - $50.07 $27,290 - $42,409	-847 Reduced 4.43%	18,293 $879,000
Q3 2019 Nov 08, 2019	BUY	$33.82 - $48.17 $69,094 - $98,411	2,043 Added 11.95%	19,140 $647,000
Q2 2019 Jul 25, 2019	SELL	$35.42 - $45.0 $8,075 - $10,260	-228 Reduced 1.32%	17,097 $769,000
Q1 2019 May 08, 2019	SELL	$28.09 - $39.49 $403,569 - $567,352	-14,367 Reduced 45.33%	17,325 $652,000
Q4 2018 Feb 05, 2019	BUY	$29.83 - $46.51 $102,585 - $159,947	3,439 Added 12.17%	31,692 $1.09 Million
Q3 2018 Nov 13, 2018	BUY	$33.9 - $47.77 $957,776 - $1.35 Million	28,253 New	28,253 $1.33 Million

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.